Prof. Uziel Sandler and Dr. Yoram Dvari, two JCT researchers, are currently developing an innovative and revolutionary solution for diabetics. The current treatment for diabetics, injecting insulin into the body, does not provide a satisfactory solution for all patients.
APC1, the new medication, allows sugar to be transferred through the body more effectively, making it easier for the body to produce insulin without assistance. The major benefit of this medication is that it doesn't require an insulin injection but encourages the body to produce it on its own.
The development of APC1 began three years ago and has shown positive results in animal testing. Within a few months, after proving its effectiveness and harmlessness, human trials will begin, and based upon their success, the medication will be presented to the FDA for approval.